CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Rilpivirine

Last Updated: July 29, 2011
Result type: Reports
Project Number: S0243
Product Line: Common Drug Review

Generic Name: Rilpivirine

Brand Name: Edurant

Manufacturer: Janssen Inc.

Indications: HIV (treatment - naive adult)

Submission Type: New

Project Status: Complete

Date Recommendation Issued: February 15, 2012

Recommendation Type: List